PHARMARON (EXTON) LAB SERVICES LLC

PHARMARON (EXTON) LAB SERVICES LLC specializes in preclinical pharmacokinetic and pharmacodynamic research services, delivering in-vivo studies to support drug development pipelines. Their core expertise lies in designing and executing rodent-based PK studies to characterize drug absorption, distribution, metabolism, and excretion—particularly for complex therapeutics such as antisense oligonucleotides and cytochrome P450 inhibitors. They demonstrate advanced capability in plasma concentration analysis, formulation optimization, and the use of zero-permeability markers like lucifer yellow to validate experimental models. The team applies rigorous analytical techniques to generate robust pharmacokinetic data that informs lead candidate selection and dosing strategies, making them a trusted partner in early-stage biopharmaceutical research. The contractor maintains a consistent relationship with the Department of Health and Human Services, providing critical preclinical data to advance public health initiatives in infectious disease and therapeutic innovation. Their work supports HHS-funded projects focused on HIV therapeutics, metabolic drug interactions, and novel formulation science, indicating a deep alignment with NIH and FDA-related research objectives. This recurring engagement suggests a track record of delivering reliable, compliant, and scientifically rigorous results within federal research ecosystems. PHARMARON operates primarily under NAICS 541714 and 541715, focusing on biotechnology and life sciences R&D that bridges molecular pharmacology with in-vivo validation. Their market positioning centers on small-molecule and oligonucleotide therapeutics, serving biotech firms and government research labs requiring high-fidelity pharmacokinetic datasets to de-risk clinical translation. They specialize in translational science that connects in-vitro findings to in-vivo outcomes. As a limited-liability entity based in Exton, Pennsylvania, PHARMARON (EXTON) LAB SERVICES LLC operates as a specialized contract research provider without federal certifications. Their geographic footprint is focused on the U.S. biopharma corridor, serving clients who require localized, high-quality preclinical services with rapid turnaround and regulatory alignment.